5 completed. 5 Not applicable.
By phase and status
Follow Fisons: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
A Double-Blind Placebo-Controlled Group Comparative Study To Evaluate the Safety and Effectiveness of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in Patients With AIDS Post First Episode PCP Pentamidine isethionate - Pneumonia, Pneumocystis Carinii, HIV Infections | Not applicable | Completed | | | 2005-06-24 |
An Open Label Study to Evaluate the Long-Term Safety and Effectiveness of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients Pentamidine isethionate - Pneumonia, Pneumocystis Carinii, HIV Infections | Not applicable | Completed | | | 2005-06-24 |
The Safety and Effectiveness of Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS Who Have Had PCP Before Pentamidine isethionate - Pneumonia, Pneumocystis Carinii, HIV Infections | Not applicable | Completed | | | 2005-06-24 |
A Double-Blind Study To Evaluate the Long-Term Safety and Effectiveness of 60 mg Versus 120 mg of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients Pentamidine isethionate - Pneumonia, Pneumocystis Carinii, HIV Infections | Not applicable | Completed | | | 2005-06-24 |
A Double-Blind Group Comparative Study To Evaluate the Long-Term Safety and Effectiveness of Two Different Doses of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients With Multiple Episodes of PCP Pentamidine isethionate - Pneumonia, Pneumocystis Carinii, HIV Infections | Not applicable | Completed | | | 2005-06-24 |
Conditions studied
AIDS-Related Opportunistic Infections (5) · Acquired Immunodeficiency Syndrome (5) · HIV Infections (5) · Pneumonia, Pneumocystis (5)
Interventions
Pentamidine (5)
Countries
United States (5)